Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vitamin K antagonists but not non-vitamin K antagonists in addition on antiplatelet therapy should be associated with increase of hematoma volume and mortality in patients with intracerebral hemorrhage: A sub-analysis of PASTA registry study.
Nomura K, Suda S, Abe A, Iguchi Y, Yagita Y, Kanzawa T, Okubo S, Fujimoto S, Kimura K; PASTA study group. Nomura K, et al. Among authors: yagita y. J Neurol Sci. 2023 May 15;448:120643. doi: 10.1016/j.jns.2023.120643. Epub 2023 Apr 1. J Neurol Sci. 2023. PMID: 37028263
High pre-stroke CHADS2 score predicts unfavorable functional outcome in acute cardioembolic stroke patients prescribed oral anticoagulant therapy: A sub-analysis of the PASTA registry study.
Sakai K, Suda S, Iguchi Y, Abe A, Yagita Y, Kanzawa T, Okubo S, Fujimoto S, Kimura K. Sakai K, et al. Among authors: yagita y. J Stroke Cerebrovasc Dis. 2024 Feb;33(2):107519. doi: 10.1016/j.jstrokecerebrovasdis.2023.107519. Epub 2023 Dec 23. J Stroke Cerebrovasc Dis. 2024. PMID: 38142567
Carotid intima-media thickness and risk of cardiovascular events in high-risk patients. Results of the Osaka Follow-Up Study for Carotid Atherosclerosis 2 (OSACA2 Study).
Kitagawa K, Hougaku H, Yamagami H, Hashimoto H, Itoh T, Shimizu Y, Takahashi D, Murata S, Seike Y, Kondo K, Hoshi T, Furukado S, Abe Y, Yagita Y, Sakaguchi M, Tagaya M, Etani H, Fukunaga R, Nagai Y, Matsumoto M, Hori M; OSACA2 Study Group. Kitagawa K, et al. Among authors: yagita y. Cerebrovasc Dis. 2007;24(1):35-42. doi: 10.1159/000103114. Epub 2007 May 22. Cerebrovasc Dis. 2007. PMID: 17519542
Clinical characteristics and tumor markers in ischemic stroke patients with active cancer.
Nezu T, Hosomi N, Naito H, Aoki S, Torii T, Kurashige T, Sugiura T, Kuzume D, Morimoto Y, Yoshida T, Yagita Y, Oyama N, Shiga Y, Kinoshita N, Kamimura T, Ueno H, Ohshita T, Maruyama H. Nezu T, et al. Among authors: yagita y. Intern Emerg Med. 2022 Apr;17(3):735-741. doi: 10.1007/s11739-021-02862-1. Epub 2021 Oct 1. Intern Emerg Med. 2022. PMID: 34596824
The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study.
Hosomi N, Nagai Y, Kohriyama T, Ohtsuki T, Aoki S, Nezu T, Maruyama H, Sunami N, Yokota C, Kitagawa K, Terayama Y, Takagi M, Ibayashi S, Nakamura M, Origasa H, Fukushima M, Mori E, Minematsu K, Uchiyama S, Shinohara Y, Yamaguchi T, Matsumoto M; J-STARS Collaborators. Hosomi N, et al. EBioMedicine. 2015 Aug 6;2(9):1071-8. doi: 10.1016/j.ebiom.2015.08.006. eCollection 2015 Sep. EBioMedicine. 2015. PMID: 26501105 Free PMC article. Clinical Trial.
Associations between Pre-Admission Risk Scores and Two-Year Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients with Non-Valvular Atrial Fibrillation.
Tokunaga K, Yamagami H, Koga M, Todo K, Kimura K, Itabashi R, Terasaki T, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Kameda T, Nagakane Y, Hasegawa Y, Shibuya S, Ito Y, Matsuoka H, Takamatsu K, Nishiyama K, Kario K, Yagita Y, Kitazono T, Kinoshita N, Takasugi J, Okata T, Yoshimura S, Sato S, Arihiro S, Toyoda K; SAMURAI Study Investigators. Tokunaga K, et al. Among authors: yagita y. Cerebrovasc Dis. 2018;45(3-4):170-179. doi: 10.1159/000487896. Epub 2018 Mar 29. Cerebrovasc Dis. 2018. PMID: 29597211
162 results